These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17690133)

  • 21. Role of peroxisome proliferator-activated receptor alpha (PPARα) and PPARα-mediated species differences in triclosan-induced liver toxicity.
    Tang Y; M Vanlandingham M; Wu Y; Beland FA; Olson GR; Fang JL
    Arch Toxicol; 2018 Nov; 92(11):3391-3402. PubMed ID: 30238133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation.
    Shah YM; Morimura K; Yang Q; Tanabe T; Takagi M; Gonzalez FJ
    Mol Cell Biol; 2007 Jun; 27(12):4238-47. PubMed ID: 17438130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans.
    Hertz R; Bar-Tana J
    Toxicol Lett; 1998 Dec; 102-103():85-90. PubMed ID: 10022237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.
    Rosen MB; Lee JS; Ren H; Vallanat B; Liu J; Waalkes MP; Abbott BD; Lau C; Corton JC
    Toxicol Sci; 2008 May; 103(1):46-56. PubMed ID: 18281256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
    Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.
    Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG
    Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.
    Soria A; González Mdel C; Vidal H; Herrera E; Bocos C
    Mol Cell Biochem; 2005 May; 273(1-2):97-107. PubMed ID: 16013444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.
    Hennuyer N; Poulain P; Madsen L; Berge RK; Houdebine LM; Branellec D; Fruchart JC; Fiévet C; Duverger N; Staels B
    Circulation; 1999 May; 99(18):2445-51. PubMed ID: 10318668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
    Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
    Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice.
    Guo Q; Wang G; Namura S
    J Cereb Blood Flow Metab; 2010 Jan; 30(1):70-8. PubMed ID: 19724288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPAR alpha and thyroid hormone receptors.
    Jow L; Mukherjee R
    J Biol Chem; 1995 Feb; 270(8):3836-40. PubMed ID: 7876127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.
    Kersten S; Stienstra R
    Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The whole transcriptome effects of the PPARα agonist fenofibrate on livers of hepatocyte humanized mice.
    de la Rosa Rodriguez MA; Sugahara G; Hooiveld GJEJ; Ishida Y; Tateno C; Kersten S
    BMC Genomics; 2018 Jun; 19(1):443. PubMed ID: 29879903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
    Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
    Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice and beagle dogs.
    Kasai S; Inoue T; Yoshitomi H; Hihara T; Matsuura F; Harada H; Shinoda M; Tanaka I
    J Pharmacol Sci; 2008 Sep; 108(1):40-8. PubMed ID: 18776709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor alpha-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells.
    Yamashita M
    Eur J Pharmacol; 2007 Feb; 556(1-3):172-80. PubMed ID: 17113579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of P450 4A expression by peroxisome proliferator activated receptors.
    Johnson EF; Hsu MH; Savas U; Griffin KJ
    Toxicology; 2002 Dec; 181-182():203-6. PubMed ID: 12505311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPARalpha regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes.
    Thulin P; Rafter I; Stockling K; Tomkiewicz C; Norjavaara E; Aggerbeck M; Hellmold H; Ehrenborg E; Andersson U; Cotgreave I; Glinghammar B
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):1-9. PubMed ID: 18455211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.